S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

HCWB HCW Biologics Inc

0.414

-0.0156 (-3.63%)

Pre Market

Last Updated: 06:46:30

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

HCW Biologics (NASDAQ:HCWB)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more HCW Biologics Charts.

HCW Biologics (NASDAQ:HCWB)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more HCW Biologics Charts.

HCW Biologics Inc News

Form 8-K - Current report
Monday 3 February 2025 (4 days ago) • Edgar (US Regulatory)

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Monday 3 February 2025 (4 days ago) • GlobeNewswire Inc.

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025
Wednesday 15 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

HCW Biologics Inc. Received NASDAQ Staff Determination Letter
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Thursday 5 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 22 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B2 - Prospectus [Rule 424(b)(2)]
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
Monday 18 November 2024 (3 months ago) • GlobeNewswire Inc.

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
Monday 18 November 2024 (3 months ago) • GlobeNewswire Inc.

More HCW Biologics Inc News Articles

Korab Resources

Wilson Sons Holdings Bra... ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions